Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 350

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 350
---
 |     | -130,185 |     | (19)%    |
| Total operating expenses                   |     |                                  1,833,977 |     |  1,933,982 |     | -100,005 |     | (5)%     |
| Loss from operations                       |     |                                 -1,833,977 |     | -1,933,982 |     |  100,005 |     | (5)%     |
| Other expense                              |     |                                   -133,634 |     |   -628,348 |     |  494,714 |     | (79)%    |
| Net loss before provision for income taxes |     |                                 -1,967,611 |     | -2,562,330 |     |  594,719 |     | (23)%    |
| Provision for income taxes                 |     |                                          — |     |          — |     |        — |     | NA       |
| Net loss                                   |     |                               $(1,967,611) |     | -2,562,330 |     |  594,719 |     | (23)%    |

195

TABLE OF CONTENTS

Operating Expenses Channel’s operating expenses consist of general and administrative expenses, research and development expenses and professional fees. General and Administrative Expenses Channel incurred general and administrative expenses for the three months ended March 31, 2025 and 2024 of $1,090,049 and $787,561, respectively. For the three months ended March 31, 2025, compared to the same period in 2024, this represented an increase of $302,488, or 38%, primarily as a result of increases of $173,686 in compensation expenses and an increase of $163,279 in stock compensation. Research and Development Expenses Channel incurred research and development expenses for the three months ended March 31, 2025 and 2024 of $194,298, and $466,606, respectively. For the three months ended March 31, 2025, compared to the same period in 2024, this represented a decrease of $272,308, or 58%, with the details set forth in the table below:

|                                              |     | Three Months Ended March 31, 2025 and 2024 
                                       2025 |     |     2024 |     |   $ Change |     | % Change |
|:---------------------------------------------|:----|--------------------------------